Publication | Open Access
T<sub>1</sub>&ndash;T<sub>2</sub> molecular magnetic resonance imaging of renal carcinoma cells based on nano-contrast agents
50
Citations
44
References
2018
Year
A T<sub>1</sub>-T<sub>2</sub> dual-mode contrast agent, Fe<sub>3</sub>O<sub>4</sub>@mSiO<sub>2</sub>/PDDA/BSA-Gd<sub>2</sub>O<sub>3</sub> nano-complex, was developed and its good performance for tumor cell targeting in vitro and kidney contrast-enhanced MRI in mice indicated its promising potential as an effective T<sub>1</sub>-T<sub>2</sub> dual-mode contrast agent for in vivo MRI with self-confirmation.
| Year | Citations | |
|---|---|---|
Page 1
Page 1